Mark Cuban's 7-Point Healthcare Reality Check for Elon Musk and Other CEOs
When Elon Musk took to X last year asking why Americans can't afford healthcare, he probably didn't expect another billionaire to respond — let alone with a seven-point takedown of the entire system.
But Mark Cuban didn't just answer the question. He diagnosed the problem, called out who's responsible, and proposed a solution bold enough to shake up the pharmaceutical industry.
Up Next: Jaspreet Singh Warns of 7 Wealth Killers & Gives Tips on How To Handle Them
Check Out: 9 Unusual Ways To Make Extra Money (That Actually Work)
Here's the seven-point reality check Cuban delivered.
1. You Don't Even Own Your Own Data
When businesses sign with a big pharmacy benefit manager (PBM), they give up access to their own claims data, meaning they can't even see where their money is really going. No data means no power to negotiate better deals.
Instead of pointing fingers at the government or the system at large, Cuban argued that self-insured companies are part of the problem because of the contracts they sign with insurers and PBMs. These deals, he claimed, lock businesses into an overpriced system that benefits everyone -- except the patients and the companies footing the bill.
2. The Drugs Your Employees Get? Not Your Choice
PBMs -- not the companies paying the bill -- decide which drugs employees can access. This often means prioritizing expensive medications over more effective, cheaper alternatives.
It reflects a growing sentiment that Americans are paying exorbitant healthcare costs but not receiving adequate value.
3. 'Specialty Drugs' Are a Pricing Scam
Cuban called out one of the biggest rip-offs in healthcare -- so-called "specialty drugs" that aren't actually special. PBMs mark up the price, forcing employers to pay more, even when identical alternatives exist at a fraction of the cost.
4. Your Sickest Employees Are Subsidizing the System
PBMs structure rebates so that the sickest and oldest employees end up shouldering the highest costs, leading to higher deductibles, bigger co-pays and worse health outcomes.
Don't Miss: Enter for a Chance To Win $500 in MoneyLion's Summer Break Giveaway (No pur. nec. Ends 7/4/26. See Official Rules at mlion.info/summerbreakofficialrules)
5. Independent Pharmacies Get Crushed -- And That Hurts Everyone
PBM contracts reimburse independent pharmacies at rates lower than their actual costs, forcing them out of business. Fewer pharmacies mean less competition -- which means higher prices and less access for consumers.
6. CEOs Are Handcuffed From Negotiating Better Deals
PBM contracts ban direct negotiations with drug manufacturers, blocking companies from securing better pricing for employees.
7. You Signed a Contract That Silences You
These contracts come with NDAs, meaning even if a CEO wants to talk about the company's PBM deal, they legally couldn't. This secrecy keeps CEOs in the dark and prevents businesses from exposing the system.
Cuban's Fix: A Direct-to-Consumer Pharmaceutical Model
Cuban isn't just talking -- he's actively working to disrupt the system. His company, Cost Plus Drugs, eliminates PBMs entirely, selling medications directly to consumers with full transparency -- no hidden fees or artificial markups.
Musk's question may have been simple, but Cuban's answer could be a wake-up call. If his model takes off, it could be the disruption the industry desperately needs.
Caitlyn Moorhead contributed to the reporting for this article.
Summer spending adds up fast. Enter MoneyLion's Summer Break Giveaway for a chance to win $500— and give your budget a break. (No pur. nec. Ends 7/4/26. See Official Rules at mlion.info/summerbreakofficialrules)
This article was provided by MoneyLion.com for informational purposes only and should not be construed as financial, legal or tax advice.
More From MoneyLion:
How Middle-Class Earners Are Quietly Becoming Millionaires — and How You Can, Too
Gen Z Workers Are Falling Behind on the Most Basic Money Milestone: Emergency Savings